Home
>
National Drug Code (NDC)
>
Livalo
Livalo - 66869-204-07 - (pitavastatin calcium)
Drug Information of Livalo
| Product NDC: | 66869-204 |
| Proprietary Name: | Livalo |
| Non Proprietary Name: | pitavastatin calcium |
| Active Ingredient(s): | 2.09 mg/1 & nbsp; pitavastatin calcium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Livalo
| Product NDC: | 66869-204 |
| Labeler Name: | Kowa Pharmaceuticals America, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022363 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100515 |
Package Information of Livalo
| Package NDC: | 66869-204-07 |
| Package Description: | 7 TABLET, FILM COATED in 1 CARTON (66869-204-07) |
NDC Information of Livalo
| NDC Code | 66869-204-07 |
| Proprietary Name | Livalo |
| Package Description | 7 TABLET, FILM COATED in 1 CARTON (66869-204-07) |
| Product NDC | 66869-204 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | pitavastatin calcium |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20100515 |
| Marketing Category Name | NDA |
| Labeler Name | Kowa Pharmaceuticals America, Inc. |
| Substance Name | PITAVASTATIN CALCIUM |
| Strength Number | 2.09 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
